Forge Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Forge Therapeutics's estimated annual revenue is currently $3.8M per year.
- Forge Therapeutics's estimated revenue per employee is $104,000
Employee Data
- Forge Therapeutics has 37 Employees.
Forge Therapeutics's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Co-Founder COO & VP Discovery | Reveal Email/Phone |
2 | Scientific Co-Founder | Reveal Email/Phone |
3 | SVP | Reveal Email/Phone |
Forge Therapeutics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $1.8M | 27 | -4% | $15.7M | N/A |
#2 | $25.5M | 178 | -3% | N/A | N/A |
#3 | $1.4M | 22 | -50% | $21.2M | N/A |
#4 | $56.6M | 348 | 19% | $6M | N/A |
#5 | $6.3M | 56 | -21% | $216.8M | N/A |
#6 | $0M | 2 | 0% | $33.3M | N/A |
#7 | $33.3M | 233 | 0% | N/A | N/A |
#8 | $32.4M | 232 | -26% | $64.6M | N/A |
#9 | $30M | 215 | -22% | $46.8M | N/A |
#10 | $261.6M | 1407 | 15% | $75M | N/A |
What Is Forge Therapeutics?
N/A
Total Funding
37
Number of Employees
$3.8M
Revenue (est)
N/A
Employee Growth %
N/A
Valuation
N/A
Accelerator
Forge Therapeutics News
2022-04-17 - Forge Biologics to Present at Chardan's 6th Annual Genetic ...
Forge Biologics is a hybrid gene therapy contract manufacturing and clinical-stage therapeutics development company. Forge's mission is to...
2022-04-17 - Allogene Therapeutics Unveils Cell Forge 1, a Uniquely ...
Allogene Therapeutics Unveils Cell Forge 1, a Uniquely Designed Manufacturing Facility to Deliver AlloCAR T Products.
2022-04-17 - Allogene Therapeutics Unveils Cell Forge 1, a Uniquely Designed
Manufacturing Facility to Deliver AlloCAR T Products
Allogene Therapeutics, Inc. Interactive Experience Designed to Showcase the 136,000sf cGMP Facility Located in Newark, California. Cell Forge 1...
Other Companies in
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $7.4M | 37 | -10% | N/A |
#2 | $6.7M | 37 | 28% | N/A |
#3 | $4.4M | 37 | -12% | N/A |
#4 | $7.5M | 37 | 12% | N/A |
#5 | $4.4M | 37 | 3% | N/A |